Find Methotrexate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

229 RELATED EXCIPIENT COMPANIES

367EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 59-05-2, Amethopterin, Rheumatrex, Methylaminopterin, Abitrexate, Trexall
Molecular Formula
C20H22N8O5
Molecular Weight
454.4  g/mol
InChI Key
FBOZXECLQNJBKD-ZDUSSCGKSA-N
FDA UNII
YL5FZ2Y5U1

Methotrexate
An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.
Methotrexate is a Folate Analog Metabolic Inhibitor. The mechanism of action of methotrexate is as a Folic Acid Metabolism Inhibitor.
1 2D Structure

Methotrexate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
2.1.2 InChI
InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1
2.1.3 InChI Key
FBOZXECLQNJBKD-ZDUSSCGKSA-N
2.1.4 Canonical SMILES
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
2.1.5 Isomeric SMILES
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
YL5FZ2Y5U1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Amethopterin

2. Dicesium Salt Methotrexate

3. Hydrate, Methotrexate

4. Methotrexate Hydrate

5. Methotrexate Sodium

6. Methotrexate, (d)-isomer

7. Methotrexate, (dl)-isomer

8. Methotrexate, Dicesium Salt

9. Methotrexate, Disodium Salt

10. Methotrexate, Sodium Salt

11. Mexate

12. Sodium, Methotrexate

2.3.2 Depositor-Supplied Synonyms

1. 59-05-2

2. Amethopterin

3. Rheumatrex

4. Methylaminopterin

5. Abitrexate

6. Trexall

7. Mexate

8. Metatrexan

9. Hdmtx

10. Methylaminopterinum

11. Mtx

12. (s)-2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic Acid

13. Methotrexatum

14. Rasuvo

15. 4-amino-10-methylfolic Acid

16. Metotrexato

17. Maxtrex

18. Nsc-740

19. Mexate-aq

20. N-bismethylpteroylglutamic Acid

21. Folex

22. Nci-c04671

23. Cl-14377

24. Antifolan

25. Methotrexate Lpf

26. Xatmep

27. 133073-73-1

28. Amethopterine

29. Farmitrexat

30. Emt 25,299

31. L-amethopterin

32. Cl 14377

33. Methotrexat-ebewe

34. Tcmdc-125858

35. (2s)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic Acid

36. Abitrexate (methotrexate)

37. R 9985

38. Yl5fz2y5u1

39. Methotextrate

40. Methotrexat

41. Chembl34259

42. Nsc740

43. Chebi:44185

44. Adx-2191

45. N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-l-glutamic Acid

46. N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-l-glutamic Acid

47. Cl14377

48. Ncgc00025060-04

49. Nsc 740

50. 4-amino-n(10)-methylpteroylglutamic Acid

51. A-methopterin

52. Dsstox_cid_822

53. A-methpterin

54. Amethopterin L-

55. Folex-pfs

56. R-9985

57. (2s)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic Acid

58. Dsstox_rid_75810

59. Methotrexate, L-

60. Dsstox_gsid_20822

61. X 133

62. Metotressato [dcit]

63. Methotrexate, D-

64. Fauldexato

65. Medsatrexate

66. Methoblastin

67. Metotressato

68. Brimexate

69. Emthexat

70. Emthexate

71. Lantarel

72. Lumexon

73. Metrotex

74. Novatrex

75. Otrexup

76. Tremetex

77. Trexeron

78. Trixilem

79. Metex

80. Texate

81. Mls001401431

82. Methotrexatum [inn-latin]

83. Metotrexato [inn-spanish]

84. [3h]methotrexate

85. Smr000112001

86. [3h]-methotrexate

87. Folic Acid Antagonist

88. Ccris 1109

89. 4-aminomethylpteroylglutamic Acid

90. Hsdb 3123

91. L-(+)-n-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic Acid

92. N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-l-(+)-glutamic Acid

93. Sr-01000075682

94. Smr000449324

95. Einecs 200-413-8

96. Unii-yl5fz2y5u1

97. Metolate

98. Nordimet

99. Ai3-25299

100. Intradose-mtx

101. 4-amino-n(sup 10)-methylpteroylglutamic Acid

102. 1dhi

103. 1dhj

104. 2drc

105. 4ocx

106. (2s)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic Acid

107. Cas-59-05-2

108. Glutamic Acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-

109. Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-l-glutamova

110. Mpi-2505

111. Prestwick_322

112. Otrexup (tn)

113. Xatmep (tn)

114. Reditrex

115. Kyselina 4-amino-n(sup 10)-methylpteroylglutamova [czech]

116. Methylaminopterin; Mtx

117. Methotrexate [usan:usp:inn:ban:jan]

118. Spectrum_001836

119. Tocris-1230

120. 4kn0

121. Wr-19039

122. Prestwick0_000135

123. Prestwick1_000135

124. Prestwick2_000135

125. Spectrum2_001077

126. Spectrum3_000497

127. Spectrum4_000616

128. Spectrum5_000958

129. Methotrexate - Abitrexate

130. Methotrexate [mi]

131. N-(p-(((2,4-diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic Acid

132. Methotrexate [inn]

133. Methotrexate [jan]

134. L(+)-amethopterin Hydrate

135. Methotrexate [hsdb]

136. Methotrexate [iarc]

137. Methotrexate [inci]

138. Methotrexate [usan]

139. N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-l-glutamicacid

140. Ncimech_000767

141. Schembl3711

142. Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-l-glutamova [czech]

143. Methotrexate [vandf]

144. Bidd:pxr0175

145. Lopac0_000020

146. Kbiogr_001172

147. Kbioss_002341

148. Methotrexate [mart.]

149. Kyselina 4-amino-n(sup 10)-methylpteroylglutamova

150. Mls000049968

151. Mls002154208

152. Divk1c_000114

153. Methotrexate [usp-rs]

154. Methotrexate [who-dd]

155. Methotrexate [who-ip]

156. Spbio_001094

157. Spbio_002149

158. Amy235

159. Cid_126941

160. Cid_165528

161. Gtpl4674

162. Gtpl4815

163. Dtxsid4020822

164. Schembl12421860

165. Schembl23111732

166. Bdbm18050

167. Bdbm66082

168. Hms500f16

169. Kbio1_000114

170. Kbio2_002338

171. Kbio2_004906

172. Kbio2_007474

173. Kbio3_001493

174. Methotrexate (jp17/usp/inn)

175. G301

176. Ninds_000114

177. Bio1_000486

178. Bio1_000975

179. Bio1_001464

180. Hms1568k12

181. Hms2095k12

182. Hms2233o18

183. Hms3260c21

184. Hms3414l09

185. Hms3678l07

186. Hms3712k12

187. Methotrexate [orange Book]

188. Methotrexate [ep Monograph]

189. Methotrexate [usp Impurity]

190. Act03341

191. Apc-2002

192. Bcp13701

193. Mpi-5004

194. Zinc1529323

195. Methotrexate [usp Monograph]

196. Tox21_110944

197. Tox21_300269

198. Tox21_500020

199. Ccg-35800

200. Emt-25299

201. Methotrexatum [who-ip Latin]

202. Mfcd00064370

203. S1210

204. Stl535338

205. (4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-l-glutamic Acid

206. Akos016340329

207. Tox21_110944_1

208. Cs-1732

209. Db00563

210. Ks-5093

211. Lp00020

212. Sdccgsbi-0050009.p003

213. Wr19039

214. Idi1_000114

215. N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-l-glutamic Acid

216. Smp2_000020

217. (methyl)amino)benzamido)pentanedioic Acid

218. Ncgc00025060-01

219. Ncgc00025060-02

220. Ncgc00025060-03

221. Ncgc00025060-05

222. Ncgc00025060-06

223. Ncgc00025060-07

224. Ncgc00025060-08

225. Ncgc00025060-09

226. Ncgc00025060-10

227. Ncgc00025060-11

228. Ncgc00025060-12

229. Ncgc00025060-13

230. Ncgc00025060-15

231. Ncgc00025060-16

232. Ncgc00254216-01

233. Ncgc00260705-01

234. Hy-14519

235. Eu-0100020

236. G-301

237. Sw198601-3

238. Methotrexate 1.0 Mg/ml In Dimethyl Sulfoxide

239. 73m731

240. A10021

241. C01937

242. D00142

243. Q422232

244. Sr-01000597411

245. W-60383

246. (s)-2-(4-(((2,4-diaminopteridin-6-yl)methyl)

247. Q-201366

248. Sr-01000075682-1

249. Sr-01000075682-2

250. Sr-01000075682-6

251. Sr-01000597411-1

252. W-105347

253. Brd-k59456551-001-09-3

254. Brd-k59456551-001-11-9

255. Wln: T66 Bn Dn Gn Jnj Cz Ez H1n1&r Dvmyvq2vq

256. Z1541638527

257. N,n,n,n-ethylenediaminetetra(methylenephosphonicacid)

258. Methotrexate, European Pharmacopoeia (ep) Reference Standard

259. Methotrexate, United States Pharmacopeia (usp) Reference Standard

260. Glutamic Acid,4-diamino-6-pteridinyl)methyl] Methylamino]benzoyl]-, L-(+)-

261. L-glutamic Acid,4-diamino-6-pteridinyl)methyl]- Methylamino]benzoyl]-

262. (s)-2-(4-(((2,4-diaminopteridin-6-yl)methyl)-(methyl)amino)benzamido)pentanedioic Acid

263. L-glutamic Acid,n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,hydrate(9ci)

264. Methotrexate For Peak Identification, European Pharmacopoeia (ep) Reference Standard

265. Methotrexate For System Suitability, European Pharmacopoeia (ep) Reference Standard

266. Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material

267. N-[4-[[(2,4-diamino-6-pteridinyl)methyl] Methylamino]benzoyl]-l-glutamic Acid

268. (2s)-2-((4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)amino)pentanedioic Acid

269. (2s)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic Acid;hydrate

270. (2s)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric Acid;hydrate

271. (2s)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic Acid;hydrate

272. 102613-64-9

273. L-glutamic Acid,n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, Hydrate (9ci)

274. Methotrexate, Pharmagrade, Manufactured Under Appropriate Controls For Use As A Raw Material In Pharma Or Biopharmaceutical Production, Meets Ep, Usp Testing Specifications

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 454.4 g/mol
Molecular Formula C20H22N8O5
XLogP3-1.8
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count12
Rotatable Bond Count9
Exact Mass454.17131583 g/mol
Monoisotopic Mass454.17131583 g/mol
Topological Polar Surface Area211 Ų
Heavy Atom Count33
Formal Charge0
Complexity704
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameMethotrexate sodium
Drug LabelMethotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate is N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-...
Active IngredientMethotrexate sodium
Dosage FormTablet; Injectable
RouteInjection; Oral
Strengtheq 200mg base/8ml (eq 25mg base/ml); eq 250mg base/10ml (eq 25mg base/ml); eq 50mg base/2ml (eq 25mg base/ml); eq 2.5mg base; eq 100mg base/4ml (eq 25mg base/ml)
Market StatusPrescription
CompanyHospira; Roxane; Dava Pharms; Fresenius Kabi Usa; Eurohlth Intl; Mylan; Barr

2 of 4  
Drug NameTrexall
PubMed HealthMethotrexate
Drug ClassesAntineoplastic Agent, Antipsoriatic, Antirheumatic, Antirheumatic, Cytotoxic
Drug LabelTrexall (methotrexate tablets USP) (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate, USP is N-[4[[(2,4-diamino-6-pteridiny...
Active IngredientMethotrexate sodium
Dosage FormTablet
RouteOral
Strengtheq 5mg base; eq 7.5mg base; eq 15mg base; eq 10mg base
Market StatusPrescription
CompanyBarr

3 of 4  
Drug NameMethotrexate sodium
Drug LabelMethotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate is N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-...
Active IngredientMethotrexate sodium
Dosage FormTablet; Injectable
RouteInjection; Oral
Strengtheq 200mg base/8ml (eq 25mg base/ml); eq 250mg base/10ml (eq 25mg base/ml); eq 50mg base/2ml (eq 25mg base/ml); eq 2.5mg base; eq 100mg base/4ml (eq 25mg base/ml)
Market StatusPrescription
CompanyHospira; Roxane; Dava Pharms; Fresenius Kabi Usa; Eurohlth Intl; Mylan; Barr

4 of 4  
Drug NameTrexall
PubMed HealthMethotrexate
Drug ClassesAntineoplastic Agent, Antipsoriatic, Antirheumatic, Antirheumatic, Cytotoxic
Drug LabelTrexall (methotrexate tablets USP) (formerly Amethopterin) is an antimetabolite used in the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. Chemically methotrexate, USP is N-[4[[(2,4-diamino-6-pteridiny...
Active IngredientMethotrexate sodium
Dosage FormTablet
RouteOral
Strengtheq 5mg base; eq 7.5mg base; eq 15mg base; eq 10mg base
Market StatusPrescription
CompanyBarr

4.2 Therapeutic Uses

Abortifacient Agents, Nonsteroidal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Dermatologic Agents; Enzyme Inhibitors; Folic Acid Antagonists; Immunosuppressive Agents; Nucleic Acid Synthesis Inhibitors

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


Methotrexate is indicated for treatment of breast carcinoma, head and neck cancers (epidermoid), non-small cell lung carcinoma (especially squamous cell types), small cell lung carcinoma, and gestational trophoblastic tumors (gestational choriocarcinoma, chorioadenoma destruens, hydatidiform mole). /Included in US product labeling/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1911


Methotrexate is indicated for treatment of cervical carcinoma, ovarian carcinoma, bladder carcinoma, colorectal carcinoma, esophageal carcinoma, gastric carcinoma, pancreatic carcinoma, and penile carcinoma. /NOT included in US product labeling/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1911


Methotrexate is indicated for treatment of acute lymphocytic leukemia and prophylaxis and treatment of meningeal leukemia. /Included in US product labeling/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1911


For more Therapeutic Uses (Complete) data for METHOTREXATE (17 total), please visit the HSDB record page.


4.3 Drug Warning

Methotrexate is a highly toxic drug with a very low therapeutic index and a therapeutic response is not likely to occur without some evidence of toxicity. ... When methotrexate is used in combination with other antineoplastic agents and/or radiation therapy, toxic reactions may be more severe than would occur with methotrexate therapy alone. Although doses of methotrexate used in the management of psoriasis and rheumatoid arthritis are usually lower than those used in antineoplastic chemotherapy, severe toxicity may occur in any patient receiving the drug and deaths have been reported with the use of methotrexate in the management of psoriasis and rheumatoid arthritis.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1111


Methotrexate should be used with extreme caution in patients with infection, peptic ulcer, ulcerative colitis, or debility, and in very young or geriatric patients. Methotrexate should be used with extreme caution, if at all, in patients with malignant disease who have preexisting liver damage or impaired hepatic function, preexisting bone marrow depression, aplasia, leukopenia, thrombocytopenia, or anemia; the drug is usually contraindicated in patients with impaired renal function. In the management of psoriasis, methotrexate is contraindicated in patients with poor nutritional status or severe renal or hepatic disorders, those with overt or laboratory evidence of an immunodeficiency syndrome, and in those with preexisting blood dyscrasias such as bone marrow hypoplasia, leukopenia, thrombocytopenia, or clinically important anemia; relative contraindications also include cirrhosis, active or recent hepatitis, or excessive alcohol consumption. In the management of rheumatoid arthritis, methotrexate is contraindicated in patients with preexisting blood dyscrasias such as bone marrow hypoplasia, leukopenia, thrombocytopenia, or clinically important anemia; those with overt or laboratory evidence of immunodeficiency syndromes; and those with excessive alcohol consumption, alcoholic liver disease, or chronic liver disease.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1112


Elevations in serum uric acid concentrations may occur in patients receiving methotrexate as a result of cell destruction and hepatic and renal damage. In some patients, uric acid nephropathy and acute renal failure may result. Tumor lysis syndrome associated with other cytotoxic drugs (e.g., fludarabine, cladribine), also has been reported in patients with rapidly growing tumors who were receiving methotrexate. Pharmacologic and appropriate supportive treatment may prevent or alleviate this complication. Methotrexate also was reported to precipitate acute gouty arthritis in two patients being treated for psoriasis. Administration of large volumes of fluids, alkalinization of the urine, and/or administration of allopurinol may be useful in preventing acute attacks of hyperuricemia and uric acid nephropathy.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1111


Severe nephropathy manifested by azotemia, hematuria, and renal failure may occur in patients receiving methotrexate; fatalities have been reported. In one study, postmortem examination revealed extensive necrosis of the epithelium of the convoluted tubules. In patients with renal impairment, methotrexate accumulation and increased toxicity or additional renal damage may occur.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1111


For more Drug Warnings (Complete) data for METHOTREXATE (22 total), please visit the HSDB record page.


4.4 Drug Indication

Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis. Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis. Other formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin's lymphoma. It is also used in the maintenance of acute lymphocytic leukemia. Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma.


FDA Label


Nordimet is indicated for the treatment of:

- active rheumatoid arthritis in adult patients,

- polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate,

- severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids, and severe psoriatic arthritis in adult patients,

- induction of remission in moderate steroid-dependent Crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Methotrexate inhibits enzymes responsible for nucleotide synthesis which prevents cell division and leads to anti-inflammatory actions. It has a long duration of action and is generally given to patients once weekly. Methotrexate has a narrow therapeutic index. Do not take methotrexate daily.


5.2 MeSH Pharmacological Classification

Abortifacient Agents, Nonsteroidal

Non-steroidal chemical compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Nonsteroidal.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Antimetabolites, Antineoplastic

Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)


Immunosuppressive Agents

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)


Antirheumatic Agents

Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)


Dermatologic Agents

Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)


Folic Acid Antagonists

Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)


Nucleic Acid Synthesis Inhibitors

Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
METHOTREXATE
5.3.2 FDA UNII
YL5FZ2Y5U1
5.3.3 Pharmacological Classes
Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Inhibit Ovum Fertilization [PE]; Copper [CS]
5.4 ATC Code

L04AX03


L04AX03

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


L - Antineoplastic and immunomodulating agents

L01 - Antineoplastic agents

L01B - Antimetabolites

L01BA - Folic acid analogues

L01BA01 - Methotrexate


L - Antineoplastic and immunomodulating agents

L04 - Immunosuppressants

L04A - Immunosuppressants

L04AX - Other immunosuppressants

L04AX03 - Methotrexate


5.5 Absorption, Distribution and Excretion

Absorption

Methotrexate has a bioavailability of 64-90%, though this decreases at oral doses above 25mg due to saturation of the carrier mediated transport of methotrexate.. Methotrexate has a Tmax of 1 to 2 hours. oral doses of 10-15g reach serum levels of 0.01-0.1M.


Route of Elimination

Methotrexate is >80% excreted as the unchanged drug and approximately 3% as the 7-hydroxylated metabolite. Methotrexate is primarily excreted in the urine with 8.7-26% of an intravenous dose appearing in the bile.


Volume of Distribution

The volume of distribution of methotrexate at steady state is approximately 1L/kg.


Clearance

Methotrexate clearance varies widely between patients and decreases with increasing doses. Currently, predicting clearance of methotrexate is difficult and exceedingly high serum levels of methotrexate can still occur when all precautions are taken.


In adults, oral absorption of methotrexate appears to be dose dependent. Peak serum levels are reached within one to two hours. At doses of 30 mg/sq m or less, methotrexate is generally well absorbed with a mean bioavailability of about 60%. The absorption of doses greater than 80 mg/sq m is significantly less, possibly due to a saturation effect.

Physicians Desk Reference. 58th ed. Thomson PDR. Montvale, NJ 2004., p. 806


After intravenous administration, the initial volume of distribution is approximately 0.18 L/kg (18% of body weight) and steady-state volume of distribution is approximately 0.4 to 0.8 L/kg (40% to 80% of body weight).

Physicians Desk Reference. 58th ed. Thomson PDR. Montvale, NJ 2004., p. 806


Protein binding: Moderate (approximately 50%), primarily to albumin.

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1912


At serum methotrexate concentrations exceeding 0.1 umol/mL passive diffusion becomes a major means of intracellular transport of the drug. The drug is widely distributed into body tissues with highest concn in the kidneys, gallbladder, spleen, liver, and skin.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113


For more Absorption, Distribution and Excretion (Complete) data for METHOTREXATE (10 total), please visit the HSDB record page.


5.6 Metabolism/Metabolites

Methotrexate is metabolized by folylpolyglutamate synthase to methotrexate polyglutamate in the liver as well as in tissues. Gamma-glutamyl hydrolase hydrolyzes the glutamyl chains of methotrexate polyglutamates converting them back to methotrexate. A small amount of methotrexate is also converted to 7-hydroxymethotrexate.


After absorption, methotrexate undergoes hepatic and intracellular metabolism to form methotrexate polyglutamate, metabolites which by hydrolysis may be converted back to methotrexate. Methotrexate polyglutamates inhibit dihydrofolate reductase and thymidylate synthetase. Small amounts of these polyglutamate metabolites may remain in tissues for extended periods; the retention and prolonged action of these active metabolites vary among different cells, tissues, and tumors. In addition, small amounts of methotrexate polyglutamate may be converted to 7-hydroxymethotrexate; accumulation of this metabolite may become substantial following administration of high doses of methotrexate, since the aqueous solubility of 7-hydroxymethotrexate is threefold to fivefold lower than that of the parent compound. Following oral administration of methotrexate, the drug also is partially metabolized by the intestinal flora.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113


5.7 Biological Half-Life

The half life of low dose methotrexate is 3 to 10 hours in adults. The half life for high dose methotrexate is 8 to 15 hours. Pediatric patients taking methotrexate for acute lymphoblastic anemia experience a terminal half life of 0.7 to 5.8 hours. Pediatric patients taking methotrexate for juvenile idiopathic arthritis experience a half life of 0.9 to 2.3 hours.


Terminal: Low doses: 3 to 10 hours. High doses: 8 to 15 hours. Note: There is wide interindividual variation in clearance rates. Small amounts of methotrexate and its metabolites are protein-bound and may remain in tissues (kidneys, liver) for weeks to months; the presence of fluid loads, such as ascites or pleural effusion, and renal function impairment will also delay clearance.

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 1912


5.8 Mechanism of Action

Methotrexate enters tissues and is converted to a methotrexate polyglutamate by folylpolyglutamate. Methotrexate's mechanism of action is due to its inhibition of enzymes responsible for nucleotide synthesis including dihydrofolate reductase, thymidylate synthase, aminoimidazole caboxamide ribonucleotide transformylase (AICART), and amido phosphoribosyltransferase. Inhibtion of nucleotide synthesis prevents cell division. In rheumatoid arthritis, methotrexate polyglutamates inhibit AICART more than methotrexate. This inhibition leads to accumulation of AICART ribonucleotide, which inhibits adenosine deaminase, leading to an accumulation of adenosine triphosphate and adenosine in the extracellular space, stimulating adenosine receptors, leading to anti-inflammatory action.


Methotrexate and its polyglutanate metabolites reversibly inhibits dihydrofolate reductase, the enzyme that reduces folic acid to tetrahydrofolic acid. Inhibition of tetrahydrofolate formation limits the availability of one-carbon fragments necessary for synthesis of purines and the conversion of deoxyuridylate to thymidylate in the synthesis of DNA and cell reproduction. The affinity of dihydrofolate reductase for methotrexate is far greater than its affinity for folic acid or dihydrofolic acid. and, therefore, even very large doses of folic acid given simultaneously will not reverse the effects of methotrexate. Leucovorin calcium, a derivative of tetrahydrofolic acid, may block the effects of methotrexate if given shortly after the antineoplastic agent. Results of one study indicate that methotrexate also causes an increase in intracellular deoxyadenosine triphosphate, which is thought to inhibit ribonucleotide reduction, and polynucleotide ligase, an enzyme concerned in DNA synthesis and repair. Tissues with high rates of cellular proliferation such as neoplasms, psoriatic epidermis, bone marrow, the lining of the GI tract, hair matrix, and fetal cells are most sensitive to the effects of methotrexate.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113


Methotrexate ... has immunosuppressive activity, in part possibly as a result of inhibition of lymphocyte multiplication. The mechanism(s) of action in the management of rheumatoid arthritis of the drug is not known, although suggested mechanisms have included immunosuppressive and/or antiinflammatory effects.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 1113


API SUPPLIERS

read-more
read-more

01

Fermion Oy

Finland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Fermion, start the journey of your innovative API.

Flag Finland
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF ASMF, BR arrow-down AUDIT
fermion

02

Pfanstiehl

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pfanstiehl

03

Rochem International Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Rochem

04

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

05

Cohance Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Cohance

06

Fareva

Luxembourg

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Flag Luxembourg
Digital Content Digital Content
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF VMF ASMF, CN arrow-down AUDIT
Fareva Company Banner

07

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

08

CF Pharma

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCF Pharma- skilled & highly experienced European API producer based in Hungary.

Flag Hungary
Digital Content Digital Content
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
CF Pharma

09

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
HRV Global Life Sciences

10

Sichuan Elixir Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..

Flag China
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Sichuan Elixir Pharmaceuticals
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

Fermion Oy

Finland
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Fermion, start the journey of your innovative API.

Flag Finland
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2014-04-28

Pay. Date : 2014-04-17

DMF Number : 23532

Submission : 2010-01-29

Status : Active

Type : II

fermion

02

Fermion Oy

Finland
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Fermion, start the journey of your innovative API.

Flag Finland
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-06-08

Pay. Date : 2013-05-23

DMF Number : 4246

Submission : 1981-08-06

Status : Active

Type : II

fermion

03

Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39988

Submission : 2024-06-05

Status : Active

Type : II

Pfanstiehl

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Flag Luxembourg
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-10-04

Pay. Date : 2013-09-26

DMF Number : 11704

Submission : 1995-10-05

Status : Active

Type : II

Fareva Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Flag Luxembourg
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2018-11-26

Pay. Date : 2018-11-16

DMF Number : 12472

Submission : 1997-04-11

Status : Active

Type : II

Fareva Company Banner

06

Cf Pharma Ltd

Hungary
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCF Pharma- skilled & highly experienced European API producer based in Hungary.

Flag Hungary
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 25957

Submission : 2012-04-10

Status : Active

Type : II

CF Pharma

07

Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..

Flag China
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39758

Submission : 2024-03-24

Status : Active

Type : II

Sichuan Elixir Pharmaceuticals

08

Fi Europe 2024
Not Confirmed

09

Pfizer Ltd

Japan

USDMF

arrow
Fi Europe 2024
Not Confirmed

09

Pfizer Ltd

Japan
arrow
Fi Europe 2024
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4018

Submission : 1980-11-11

Status : Inactive

Type : II

blank

10

Lederle Laboratories Div American Cy...

Country

USDMF

arrow
Fi Europe 2024
Not Confirmed

10

Lederle Laboratories Div American Cy...

Country
arrow
Fi Europe 2024
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3124

Submission : 1978-02-03

Status : Inactive

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

Fermion Oy

Finland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Fermion, start the journey of your innovative API.

Flag Finland
Digital Content Digital Content

METHOTREXATE SODIUM

NDC Package Code : 12780-6690

Start Marketing Date : 2010-01-14

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

fermion

02

Fermion Oy

Finland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Fermion, start the journey of your innovative API.

Flag Finland
Digital Content Digital Content

METHOTREXATE

NDC Package Code : 12780-0491

Start Marketing Date : 1981-11-19

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

fermion

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Flag Luxembourg
Digital Content Digital Content

METHOTREXATE

NDC Package Code : 46014-1023

Start Marketing Date : 2013-05-06

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

Fareva Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Flag Luxembourg
Digital Content Digital Content

METHOTREXATE

NDC Package Code : 46014-1133

Start Marketing Date : 2017-11-29

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Fareva Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Flag Luxembourg
Digital Content Digital Content

METHOTREXATE SODIUM

NDC Package Code : 46014-1119

Start Marketing Date : 2013-06-12

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Fareva Company Banner

06

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

METHOTREXATE SODIUM

NDC Package Code : 46708-939

Start Marketing Date : 2024-01-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

07

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

METHOTREXATE

NDC Package Code : 63660-0006

Start Marketing Date : 2017-12-18

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

METHOTREXATE

NDC Package Code : 51927-1565

Start Marketing Date : 2013-06-24

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

METHOTREXATE

NDC Package Code : 49452-4601

Start Marketing Date : 2000-12-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

10

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

METHOTREXATE

NDC Package Code : 58623-0040

Start Marketing Date : 2012-03-29

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Fermion Oy

Finland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Fermion, start the journey of your innovative API.

Flag Finland
Digital Content Digital Content

Methotrexate

About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & F...

Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
fermion

02

Pfanstiehl

U.S.A
arrow
BMWS24
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Flag U.S.A
Digital Content Digital Content

Methotrexate

About the Company : Transform your biologic formulations with Pfanstiehl, the industry leader in High-Purity Low Endotoxin Low Metals Parenteral grade excipient manufacturing. Our expertise spans isol...

Transform your biologic formulations with Pfanstiehl, the industry leader in High-Purity Low Endotoxin Low Metals Parenteral grade excipient manufacturing. Our expertise spans isolation, purification, custom synthesis, and scale-up development, ensuring the highest quality injectable formulation ingredients. Whether you need gram-scale quantities or multi-ton batches, trust Pfanstiehl for the highest quality injectable grade excipients available. The leading pharmaceutical companies worldwide use Pfanstiehl excipients for their unmatched purity, lowest endotoxin, and minimal trace metals. Partner with us to elevate your biologics formulations
Pfanstiehl

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content

Methotrexate

About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...

Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quality ingredients manufactured in China. Headquartered in the Hauppauge, New York, Rochem has 16 offices spread across the globe to cater to the needs of its customers. Rochem’s operations are fully cGMP compliant and has been audited by the USFDA as well as several multinational organizations. It also trains and audits its partners to ensure all of their technologies and systems are FDA-compliant.
Rochem

04

LGM Pharma

U.S.A
arrow
BMWS24
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Methotrexate

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Flag India
Digital Content Digital Content

Methotrexate

About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...

Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
Cohance

06

Fareva

Luxembourg
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Flag Luxembourg
Digital Content Digital Content

Methotrexate

About the Company : Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes rangi...

Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production. Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, ampoules, pre-filled syringes), unidoses and multidoses BFS, solids (tablets, hard capsules, powders), semi-solids (cream, gel suppositories) and liquids (oral and external, sprays, aerosols).
Fareva Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Methotrexate

About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...

Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete sourcing solutions for pharmaceutical products from India, including technical and regulatory assistance. It believes in providing its customers with high-quality products at reasonable prices. It has always endeavored to achieve global standards in the field of pharmaceuticals and has carved out a niche for itself through new methods based on current market needs. Today, it has established itself as a truly global company, with exports to almost every continent.
Jai Radhe Sales

08

CF Pharma

Hungary
arrow
BMWS24
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCF Pharma- skilled & highly experienced European API producer based in Hungary.

Flag Hungary
Digital Content Digital Content

Methotrexate

About the Company : Established in 1996, CF Pharma Ltd. is a privately owned, independent developer & producer of APIs headquartered in Budapest, Hungary. It specializes in the development & manufactu...

Established in 1996, CF Pharma Ltd. is a privately owned, independent developer & producer of APIs headquartered in Budapest, Hungary. It specializes in the development & manufacturing of high-quality, complex APIs & advanced intermediates with proven experience in handling complex & hazardous chemistry, making it a partner of choice in the development of “difficult to make” molecules. Since 1999, 25 API manufacturing processes have been developed in its three R&D labs. It specializes in quality control & regulatory compliance, & has consistently done well in regular inspections carried out by the Hungarian authority & European agencies.
CF Pharma

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Methotrexate

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

10

arrow
BMWS24
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..

Flag China
Digital Content Digital Content

Methotrexate

About the Company : Specializing in natural & oncology APIs, we establish R&D and production platforms for new salt, crystal form & synthetic biology research. We cooperate with clients for IND, NDA, ...

Specializing in natural & oncology APIs, we establish R&D and production platforms for new salt, crystal form & synthetic biology research. We cooperate with clients for IND, NDA, ANDA, 505b(2) and P-IV challenges. Exploring macromolecular APIs, we focus on Glycans & polypeptides. Expertise in XDC drugs drives innovative research & payload production. With a global registration platform & international cGMP system, we offer API CMO/CDMO services worldwide. Our strategy combines FDF and APIs. Our labs meet GMP standards with a stable R&D team, over 10 years of experience, we've delivered 20+ successful projects.
Sichuan Elixir Pharmaceuticals
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677609000,"product":"METHOTREXATE","address":"304, TOWN CENTRE, ANDHERI KURLA ROAD, ANDHERI EAST","city":"MUMBAI","supplier":"MAC-CHEM PRODUCTS (INDIA) PVT.LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"RENATA LTD,","customerCountry":"BANGLADESH","quantity":"0.35","actualQuantity":"0.35","unit":"KGS","unitRateFc":"6000","totalValueFC":"2091.2","currency":"USD","unitRateINR":491428.57142857148,"date":"01-Mar-2023","totalValueINR":"172000","totalValueInUsd":"2091.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8173915","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"304, TOWN CENTRE, ANDHERI KURLA ROAD, ANDHERI EAST, MUMBAI","customerAddress":""},{"dataSource":"API Import","activeIngredients":"METHOTREXATE","year":"2021","qtr":"Q1","strtotime":1611858600,"product":"METHOTREXATE USP\/EP\/IP\/BP","address":"NAIR BAUG, AKURLI ROADKANDIVILI EAST","city":"MUMBAI ,MAHARASHTRA","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"","customer":"BDH INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"3200","totalValueFC":"157775.5","currency":"EUR","unitRateINR":"288480","date":"29-Jan-2021","totalValueINR":"11539200","totalValueInUsd":"157775.5","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"2549865","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"NAIR BAUG, AKURLI ROADKANDIVILI EAST"},{"dataSource":"API Import","activeIngredients":"METHOTREXATE","year":"2021","qtr":"Q2","strtotime":1621449000,"product":"METHOTREXATE USP","address":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,NAC, MANIMAJRA,","city":"CHANDIGARH.","supplier":"HANGZHOU ZHONGBAO IMP.&EXP.CORP. ","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"VENUS REMEDIES","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"2750","totalValueFC":"296.5","currency":"USD","unitRateINR":"217217","date":"20-May-2021","totalValueINR":"21721.7","totalValueInUsd":"296.5","indian_port":"DELHI AIR","hs_no":"29419090","bill_no":"4020326","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"","customerAddress":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,NAC, MANIMAJRA,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627065000,"product":"METHOTREXATE DISODIUM","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR","city":"AHMEDABAD\/GUJRAT","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFORS)","customer":"ZYDUS LIFESCIENCES","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"5650","totalValueFC":"114324","currency":"USD","unitRateINR":"426010","date":"24-Jul-2021","totalValueINR":"8520200","totalValueInUsd":"114324","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1002864","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFORS)","supplierAddress":"KOIVU-MANKKAAN TIE 6 A P.O.BOX 28,F1-02101 ESPOO , FINLAND","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1628793000,"product":"METHOTREXATE (BCD: LIST 3, SL NO: 29, IGST: LIST 1, SL NO: 29)","address":"PLOT NO.2, MAITHRIVIHAR, AMEERPET,","city":"HYDERABAD, AP.","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"EUGIA PHARMA SPECIALITIES ","customerCountry":"INDIA","quantity":"4.39","actualQuantity":"4.389","unit":"KGS","unitRateFc":"4900","totalValueFC":"25937.5","currency":"EUR","unitRateINR":"438305","date":"13-Aug-2021","totalValueINR":"1923720.65","totalValueInUsd":"25937.5","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"5038604","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"","customerAddress":"PLOT NO.2, MAITHRIVIHAR, AMEERPET,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1633285800,"product":"METHOTREXATE DISODIUM SALT MILLED NP, BATCH NO:2109404","address":"Block No. 193 Part 211 Part, Xcelon Industrial Park,Chakde India Weigh","city":"Bridge Rd Vasana Chacharwadi Tal Sa","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"FTF PHARMA PRIVATE ","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"5500","totalValueFC":"1948.2","currency":"EUR","unitRateINR":"486475","date":"04-Oct-2021","totalValueINR":"145942.5","totalValueInUsd":"1948.2","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"5686853","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Block No. 193 Part 211 Part, Xcelon Industrial Park,Chakde India Weigh"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637001000,"product":"CHEMICAL : METHOTREXATE PH EUR","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3600","totalValueFC":"12776.5","currency":"EUR","unitRateINR":"317160","date":"16-Nov-2021","totalValueINR":"951480","totalValueInUsd":"12776.5","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"6276651","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641407400,"product":"METHOTREXATE IP\/USP, BATCH NO. 2041437,M\/D 08.03.2021, E\/D 07.03.2026","address":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,","city":"NEW DELHI,DELHI","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"FRESENIUS SE & CO. KGAA","customerCountry":"INDIA","quantity":"12.53","actualQuantity":"12525","unit":"GMS","unitRateFc":"3.8","totalValueFC":"56032.9","currency":"EUR","unitRateINR":"333.3","date":"06-Jan-2022","totalValueINR":"4174081.5","totalValueInUsd":"56032.9","indian_port":"DELHI AIR","hs_no":"29224290","bill_no":"6974484","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"","customerAddress":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645641000,"product":"METHOTREXATE DISODIUM SALT MILLED NP (LIST NO 3,SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"D\u00bfSSELDORF","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"4010.8","totalValueFC":"81385.2","currency":"USD","unitRateINR":"305019","date":"24-Feb-2022","totalValueINR":"6100380","totalValueInUsd":"81385.2","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1000766","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"D\u00bfSSELDORF","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645641000,"product":"METHOTREXATE DISODIUM SALT MILLED NP (LIST NO 3,SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"D\u00bfSSELDORF","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"151.00","actualQuantity":"151","unit":"KGS","unitRateFc":"4000.1","totalValueFC":"612830.3","currency":"USD","unitRateINR":"304211","date":"24-Feb-2022","totalValueINR":"45935861","totalValueInUsd":"612830.3","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1000766","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"D\u00bfSSELDORF","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655749800,"product":"METHOTREXATE USP\/EP\/IP\/BP","address":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928","city":"MUMBAI MAHARASHTRA","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"NA","customer":"BDH INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"68.60","actualQuantity":"68.6","unit":"KGS","unitRateFc":"3200","totalValueFC":"233827.4","currency":"EUR","unitRateINR":"265920","date":"21-Jun-2022","totalValueINR":"18242112","totalValueInUsd":"233827.4","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"9210926","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658341800,"product":"METHOTREXATE DISODIUM SALT MILLED NP","address":"F 2, NO.18-17, CITY HOME RESIDENCY, RD NO.3, KAMALA NAGAR, DILSUKHNAGAR","city":"HYDERABAD, AP.","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"SP ACCURE LABS PVT. LTD","customerCountry":"INDIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"5500","totalValueFC":"8523.2","currency":"EUR","unitRateINR":"451825","date":"21-Jul-2022","totalValueINR":"677737.5","totalValueInUsd":"8523.2","indian_port":"HYDERABAD AIR","hs_no":"29182990","bill_no":"9647696","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"F 2, NO.18-17, CITY HOME RESIDENCY, RD NO.3, KAMALA NAGAR, DILSUKHNAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661193000,"product":"METHOTREXATE DISODIUM SALT MILLED NP (LIST NO 3,SR NO.29)(29335990)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"24.00","actualQuantity":"24","unit":"KGS","unitRateFc":"3599.4","totalValueFC":"87398","currency":"USD","unitRateINR":"289750.5","date":"23-Aug-2022","totalValueINR":"6954012","totalValueInUsd":"87398","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1003422","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662921000,"product":"METHOTREXATE DISODIUM SALT MILLED NP US (LISTNO 3,SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"130.00","actualQuantity":"130","unit":"KGS","unitRateFc":"3544.9","totalValueFC":"462614.1","currency":"USD","unitRateINR":"285187.5","date":"12-Sep-2022","totalValueINR":"37074375","totalValueInUsd":"462614.1","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1003750","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664735400,"product":"CHEMICAL : METHOTREXATE PH.EUR [LIST NO.03-SR NO.29]","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"3600","totalValueFC":"3535.1","currency":"EUR","unitRateINR":"290880","date":"03-Oct-2022","totalValueINR":"290880","totalValueInUsd":"3535.1","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"2714660","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665945000,"product":"METHOTREXATE USP\/EP\/IP\/BP","address":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928","city":"MUMBAI MAHARASHTRA","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"NA","customer":"BDH INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"70.00","actualQuantity":"70","unit":"KGS","unitRateFc":"3200","totalValueFC":"224315.2","currency":"EUR","unitRateINR":"263680","date":"17-Oct-2022","totalValueINR":"18457600","totalValueInUsd":"224315.2","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"2911456","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NAIR BAUG, AKURLI ROAD KANDIVILI EAST Contact No: 91986928"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670178600,"product":"METHOTREXATE EP\/BP\/IP\/USP\/PH.EUR.(LIST NO.03 - SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"3500","totalValueFC":"14636","currency":"EUR","unitRateINR":"301525","date":"05-Dec-2022","totalValueINR":"1206100","totalValueInUsd":"14636","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"3597304","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"158780 METHOTREXATE BATCH NO. 2113770","address":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,","city":"NEW DELHI,DELHI","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"NA","customer":"FRESENIUS SE & CO. KGAA","customerCountry":"INDIA","quantity":"6.28","actualQuantity":"6275","unit":"GMS","unitRateFc":"3.8","totalValueFC":"26056.6","currency":"EUR","unitRateINR":"343","date":"28-Feb-2023","totalValueINR":"2152011.25","totalValueInUsd":"26056.6","indian_port":"DELHI AIR","hs_no":"29224290","bill_no":"4829777","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"B-310, SOM DATT CHAMBERS, 1,,BHIKA JI CAMA PLACE,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1688581800,"product":"METHOTREXATE DISODIUM. BATCH NO. 2140274 MAT. NO. 127104","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFORS)","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"38.00","actualQuantity":"38","unit":"KGS","unitRateFc":"5003.1","totalValueFC":"192109.4","currency":"USD","unitRateINR":"415510.1","date":"06-Jul-2023","totalValueINR":"15789383","totalValueInUsd":"192109.4","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1002878","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFORS)","supplierAddress":"KOIVU - MANKKAAN TIE 6 A, P.O.BOX 28 FI - 02101 ESPOO, FI","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702060200,"product":"METHOTREXATE USP","address":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,","city":"CHANDIGARH.","supplier":"HANGZHOU ZHONGBAO IMP.&EXP.CORP. ","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"VENUS REMEDIES","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"2700","totalValueFC":"273.4","currency":"USD","unitRateINR":"227610","date":"09-Dec-2023","totalValueINR":"22761","totalValueInUsd":"273.4","indian_port":"Delhi Air","hs_no":"29419090","bill_no":"9148659","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"13F\/E -8 BUILDING WESTPORT NEW TERRITORIES NO.206 ZHENHUA RD,HANGZHOU310030 Hangzhou, , CHINA CHINA","customerAddress":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706034600,"product":"METHOTREXATE (CAS NO.59-05-02) (LIST 3 SR NO.29; IGST LIST NO.1 SR NO.29)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"CIPLA","customerCountry":"INDIA","quantity":"80.00","actualQuantity":"80","unit":"KGS","unitRateFc":"3550","totalValueFC":"315397.2","currency":"EUR","unitRateINR":"327665","date":"24-Jan-2024","totalValueINR":"26213200","totalValueInUsd":"315397.2","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"9809275","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NUMBERGER STR.12D-90537 FEUCHTSDNF GERMANY","customerAddress":"MUMBAI CENTRAL,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709577000,"product":"METHOTREXATE DISODIUM (CAS NO:7413-34-5)","address":"PLOT NO.2, MAITHRIVIHAR,","city":"HYDERABAD, AP.","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"EUGIA PHARMA SPECIALITIES ","customerCountry":"INDIA","quantity":"81.30","actualQuantity":"81.3","unit":"KGS","unitRateFc":"4990","totalValueFC":"409909.3","currency":"USD","unitRateINR":"418661","date":"05-Mar-2024","totalValueINR":"34037139.3","totalValueInUsd":"409909.3","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2424749","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"KOIVU-MANKKAAN TIE 6 A, P.O.BOX 28FI-02200 ESPOOSDNF Finland","customerAddress":"PLOT NO.2, MAITHRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710959400,"product":"METHOTREXATE USP","address":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,","city":"CHANDIGARH.","supplier":"HANGZHOU ZHONGBAO IMP.&EXP.CORP. ","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"VENUS REMEDIES","customerCountry":"INDIA","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"2700","totalValueFC":"21785.8","currency":"USD","unitRateINR":"226125","date":"21-Mar-2024","totalValueINR":"1809000","totalValueInUsd":"21785.8","indian_port":"Delhi Air","hs_no":"29419090","bill_no":"2672509","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"13F\/E -8 BUILDING WESTPORT NEW TERRITORIES NO.206 ZHENHUA RD,HANGZHOU310030 Hangzhou, , CHINA CHINA","customerAddress":"S.C.O.857, CABIN NO. 10, 2ND FLOOR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"METHOTREXATE DISODIUM USP","address":"76, C.P.RAMASAMY ROAD,","city":"CHENNAI, TAMIL NADU","supplier":"FLAVINE","supplierCountry":"GERMANY","foreign_port":"N|RNBERG (NUREMBERG)","customer":"APEX LABORATORIES","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"28333.3","totalValueFC":"8585.8","currency":"USD","unitRateINR":"2389916.7","date":"06-Apr-2024","totalValueINR":"716975","totalValueInUsd":"8585.8","indian_port":"Madras Air","hs_no":"29335990","bill_no":"2903855","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"N|RNBERG (NUREMBERG)","supplierAddress":"61 SOUTH PARAMUS ROAD SUITE 565PARAMUS NEW JERSEYSDNF US","customerAddress":"76, C.P.RAMASAMY ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"METHOTREXATE PH.EUR. (LIST NO.03 - SR NO.29)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"D\u00bfSSELDORF","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"3775.9","totalValueFC":"76420.9","currency":"USD","unitRateINR":"318500","date":"16-May-2024","totalValueINR":"6370000","totalValueInUsd":"76420.9","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1001783","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"D\u00bfSSELDORF","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717698600,"product":"METHOTREXATE DISODIUM","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFORS)","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"44.00","actualQuantity":"44","unit":"KGS","unitRateFc":"4990","totalValueFC":"221718.2","currency":"USD","unitRateINR":"420657","date":"07-Jun-2024","totalValueINR":"18508908","totalValueInUsd":"221718.2","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1002101","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFORS)","supplierAddress":"KOIVU-MANKKAAN TIE 6 A FI-02200 ESP OO FINLAND P.O. BOX 28,02101 FI ESP OO FINLAND FINLAND","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722191400,"product":"(N.C.V.) METHOTREXATE DISODIUM (T\/L # SW\/ND\/CT-17\/2024\/000002821)","address":"48, KANDIVLI INDUSTRIAL ESTATE,","city":"MUMBAI, MAHARASHTRA.","supplier":"FERMION OY","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"IPCA LABORATORIES","customerCountry":"INDIA","quantity":"2.87","actualQuantity":"2.87","unit":"KGS","unitRateFc":"4600","totalValueFC":"14640.6","currency":"EUR","unitRateINR":"426420","date":"29-Jul-2024","totalValueINR":"1223825.4","totalValueInUsd":"14640.6","indian_port":"Bombay Air","hs_no":"29419090","bill_no":"4768290","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"KOIVU-MANKKAAN TIE 6 A, P.O.BOX 28FI-02101 ESPOO ., , FinlandSDNF Finland","customerAddress":"48, KANDIVLI INDUSTRIAL ESTATE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724265000,"product":"METHOTREXATE DISODIUM","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR","city":"AHMEDABAD\/GUJRAT","supplier":"FERMION QY","supplierCountry":"FINLAND","foreign_port":"HELSINKI (HELSINGFOR","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"4990","totalValueFC":"100955.9","currency":"USD","unitRateINR":"423401.5","date":"22-Aug-2024","totalValueINR":"8468030","totalValueInUsd":"100955.9","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"5185117","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI (HELSINGFOR","supplierAddress":"Koivu-Mankkam Tie 6A P.O.Box.28,Espoo SDNF Finland","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724610600,"product":"METHOTREXATE SODIUM ( METHOTREXATE DISODIUM SALT MILLED)","address":"ALEMBIC ROAD","city":"GUJARAT","supplier":"FLAVINE","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"ALEMBIC PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"149.78","actualQuantity":"149.78","unit":"KGS","unitRateFc":"3600","totalValueFC":"545452.9","currency":"USD","unitRateINR":"305460","date":"26-Aug-2024","totalValueINR":"45751798.8","totalValueInUsd":"545452.9","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"5257156","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"61 SOUTH PARAMUS ROAD,SUITE 565 PARMUS,NEW JERSEY 07652SDNF U.S.A.","customerAddress":"ALEMBIC ROAD"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1727980200,"product":"METHOTREXATE (LIST 3 SR NO.29; IGST LIST NO.1 SR NO.29)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"CIPLA","customerCountry":"INDIA","quantity":"36.30","actualQuantity":"36300","unit":"GMS","unitRateFc":"3.4","totalValueFC":"138436.4","currency":"EUR","unitRateINR":"320.5","date":"04-Oct-2024","totalValueINR":"11632335","totalValueInUsd":"138436.4","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"5954534","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NUMBERGER STR.12 D-90537 FEUCHT SDNF GERMANY","customerAddress":"MUMBAI CENTRAL,"}]
29-Jan-2021
04-Oct-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

arrow
Fi Europe 2024
Not Confirmed

Methotrexate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 40233

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

02

arrow
Fi Europe 2024
Not Confirmed

Methotrexate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic ANDA Granted, Available outside USA

Registration Country : Canada

Fermion Orion Company Banner

03

arrow
Fi Europe 2024
Not Confirmed

metotrexat

Brand Name : Methotrexate Orion

Dosage Form : TABLETT

Dosage Strength : 2,5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Fermion Orion Company Banner

04

arrow
Fi Europe 2024
Not Confirmed

metotrexat

Brand Name : Methotrexate Orion

Dosage Form : INJEKTIONSVÄTSKA, LÖSNING, FÖRFYLLD SPRUTA

Dosage Strength : 25 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Fermion Orion Company Banner

05

arrow
Fi Europe 2024
Not Confirmed

Methotrexate

Brand Name : Methotrexate Orion

Dosage Form : Injection fluid, resolution in the finished filled syringe

Dosage Strength : 25 mg/ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Fermion Orion Company Banner

06

arrow
Fi Europe 2024
Not Confirmed

Methotrexate

Brand Name : Methotrexate Orion

Dosage Form : Injection fluid, resolution in the finished filled syringe

Dosage Strength : 25 mg/ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Fermion Orion Company Banner

07

arrow
Fi Europe 2024
Not Confirmed

Methotrexate

Brand Name : Methotrexate Orion

Dosage Form : Injection fluid, resolution in the finished filled syringe

Dosage Strength : 25 mg/ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Fermion Orion Company Banner

08

arrow
Fi Europe 2024
Not Confirmed

Methotrexate

Brand Name : Methotrexate Orion

Dosage Form : Injection fluid, resolution in the finished filled syringe

Dosage Strength : 25 mg/ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Fermion Orion Company Banner

09

arrow
Fi Europe 2024
Not Confirmed

Methotrexate

Brand Name : Methotrexate Orion

Dosage Form : Injection fluid, resolution in the finished filled syringe

Dosage Strength : 25 mg/ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Fermion Orion Company Banner

10

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Flag Poland
Digital Content Digital Content

Regulatory Info : Dossier Availability: Q3 2026

Registration Country : Poland

Methotrexate

Brand Name :

Dosage Form : Solution for Injection

Dosage Strength : 50MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability: Q3 2026

Registration Country : Poland

Polfa Tarchomin
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Flag India
Digital Content Digital Content

RLD : Yes

TE Code :

METHOTREXATE SODIUM

Brand Name : METHOTREXATE SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1982-01-01

Application Number : 8085

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Strides Pharma Science

02

ABIC

Israel
Pharmtech & Ingredients
Not Confirmed
arrow

ABIC

Israel
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : ABITREXATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 250MG BASE/VIAL

Approval Date : 1987-07-17

Application Number : 89356

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

ACCORD HLTHCARE

United Kingdom
Pharmtech & Ingredients
Not Confirmed
arrow

ACCORD HLTHCARE

United Kingdom
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : METHOTREXATE SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2020-01-24

Application Number : 213343

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

04

BARR

U.S.A
Pharmtech & Ingredients
Not Confirmed
arrow

BARR

U.S.A
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : METHOTREXATE SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 1990-10-15

Application Number : 81099

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

Pharmtech & Ingredients
Not Confirmed
arrow
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : MEXATE-AQ PRESERVED

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 25MG BASE/ML

Approval Date : 1989-04-14

Application Number : 89887

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

06

DAITO

Japan
Pharmtech & Ingredients
Not Confirmed
arrow

DAITO

Japan
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : METHOTREXATE SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2023-08-07

Application Number : 213362

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

HOSPIRA

U.S.A
Pharmtech & Ingredients
Not Confirmed
arrow

HOSPIRA

U.S.A
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : METHOTREXATE PRESERVATIVE FREE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)

Approval Date : 2005-04-13

Application Number : 11719

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

08

MEDEXUS

Canada
Pharmtech & Ingredients
Not Confirmed
arrow

MEDEXUS

Canada
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

Brand Name : RASUVO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 20MG/0.4ML (20MG/0.4ML)

Approval Date : 2014-07-10

Application Number : 205776

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

09

QUAD PHARMS

South Africa
Pharmtech & Ingredients
Not Confirmed
arrow

QUAD PHARMS

South Africa
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : METHOTREXATE SODIUM

Dosage Form : Injectable; Injection

Dosage Strength : EQ 25MG BASE/ML

Approval Date :

Application Number : 89309

RX/OTC/DISCN :

RLD :

TE Code :

blank

10

MYLAN

U.S.A
Pharmtech & Ingredients
Not Confirmed
arrow

MYLAN

U.S.A
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Brand Name : METHOTREXATE SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 1992-05-15

Application Number : 81235

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Flag Poland
Digital Content Digital Content

Regulatory Info : Dossier Availability: Q3 2026

Registration Country : Poland

Methotrexate

Brand Name :

Dosage Form : Solution for Injection

Dosage Strength : 50MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability: Q3 2026

Registration Country : Poland

Polfa Tarchomin

01

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Flag Poland
Digital Content Digital Content

Packaging :

Regulatory Info : Dossier Availability: Q3 2026

Methotrexate

Dosage : Solution for Injection

Dosage Strength : 50MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Poland

Polfa Tarchomin

02

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Reximed

Dosage Form : Vial

Dosage Strength : 50MG/2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Vial

Dosage Strength : 50MG/2ML

Brand Name : Reximed

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

03

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Reximed

Dosage Form : Vial

Dosage Strength : 1000MG/10ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Vial

Dosage Strength : 1000MG/10ML

Brand Name : Reximed

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

04

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Reximed

Dosage Form : Vial

Dosage Strength : 50MG/2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Vial

Dosage Strength : 50MG/2ML

Brand Name : Reximed

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

05

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Reximed

Dosage Form : Vial

Dosage Strength : 1000MG/10ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

05

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Vial

Dosage Strength : 1000MG/10ML

Brand Name : Reximed

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

06

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Trexoma

Dosage Form : Prefilled Syringe

Dosage Strength : 7.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

06

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Prefilled Syringe

Dosage Strength : 7.5MG

Brand Name : Trexoma

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

07

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Trexoma

Dosage Form : Prefilled Syringe

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

07

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Prefilled Syringe

Dosage Strength : 10MG

Brand Name : Trexoma

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

08

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Trexoma

Dosage Form : Prefilled Syringe

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

08

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Prefilled Syringe

Dosage Strength : 15MG

Brand Name : Trexoma

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

09

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Trexoma

Dosage Form : Prefilled Syringe

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

09

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Prefilled Syringe

Dosage Strength : 20MG

Brand Name : Trexoma

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand

10

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Methotrexate

Brand Name : Trexoma

Dosage Form : Prefilled Syringe

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

10

NanoAlvand

Iran
arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Packaging :

Regulatory Info :

Methotrexate

Dosage : Prefilled Syringe

Dosage Strength : 25MG

Brand Name : Trexoma

Approval Date :

Application Number :

Registration Country : Iran

NanoAlvand
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INJECTION - EQ 100MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 100MG BASE/VIAL

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/V...DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/VIAL

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/4...DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 2.5GM BASE...DOSAGE - INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 2.5MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 2.5MG BASE/ML

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/VIAL

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML)

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 25MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 25MG BASE/ML

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/VIAL

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)

USFDA APPLICATION NUMBER - 11719

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (...DOSAGE - SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML...DOSAGE - SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (...DOSAGE - SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML...DOSAGE - SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (...DOSAGE - SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 22.5MG/ML (2...DOSAGE - SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 25MG/1ML (25...DOSAGE - SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML ...DOSAGE - SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML)

USFDA APPLICATION NUMBER - 210737

read-more

DOSAGE - TABLET;ORAL - EQ 2.5MG BASE **Federa...DOSAGE - TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 8085

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
Pharmtech & Ingredients
Not Confirmed

AZURITY

U.S.A
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 11969503

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208400

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-02

blank

02

arrow
Pharmtech & Ingredients
Not Confirmed

AZURITY

U.S.A
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

US Patent Number : 9855215

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208400

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-02

blank

03

arrow
Pharmtech & Ingredients
Not Confirmed

MEDEXUS

Canada
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 8664231

Drug Substance Claim :

Drug Product Claim :

Application Number : 205776

Patent Use Code : U-1442

Delist Requested :

Patent Use Description : SUBCUTANEOUS INJECTION...

Patent Expiration Date : 2029-06-01

blank

04

arrow
Pharmtech & Ingredients
Not Confirmed

SHORLA

Ireland
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 11771701

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212479

Patent Use Code : U-3701

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-10-29

blank

05

OTTER PHARMS

arrow
Pharmtech & Ingredients
Not Confirmed

OTTER PHARMS

Country
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 8562564

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

06

OTTER PHARMS

arrow
Pharmtech & Ingredients
Not Confirmed

OTTER PHARMS

Country
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 11684723

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-10

blank

07

OTTER PHARMS

arrow
Pharmtech & Ingredients
Not Confirmed

OTTER PHARMS

Country
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 10709844

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-10

blank

08

OTTER PHARMS

arrow
Pharmtech & Ingredients
Not Confirmed

OTTER PHARMS

Country
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 11684723

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-10

blank

09

OTTER PHARMS

arrow
Pharmtech & Ingredients
Not Confirmed

OTTER PHARMS

Country
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 8579865

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code : U-1442

Delist Requested :

Patent Use Description : SUBCUTANEOUS INJECTION...

Patent Expiration Date : 2030-03-19

blank

10

OTTER PHARMS

arrow
Pharmtech & Ingredients
Not Confirmed

OTTER PHARMS

Country
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
Pharmtech & Ingredients
Not Confirmed

AZURITY

U.S.A
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Exclusivity Code : ODE-137

Exclusivity Expiration Date : 2024-04-25

Application Number : 208400

Product Number : 1

Exclusivity Details :

blank

02

arrow
Pharmtech & Ingredients
Not Confirmed

AZURITY

U.S.A
arrow
Pharmtech & Ingredients
Not Confirmed

METHOTREXATE SODIUM

Exclusivity Code : ODE-138

Exclusivity Expiration Date : 2024-04-25

Application Number : 208400

Product Number : 1

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty